Structure

Physi-Chem Properties

Molecular Weight:  540.2
Volume:  531.532
LogP:  2.273
LogD:  1.843
LogS:  -4.682
# Rotatable Bonds:  5
TPSA:  153.5
# H-Bond Aceptor:  10
# H-Bond Donor:  2
# Rings:  5
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.426
Synthetic Accessibility Score:  5.352
Fsp3:  0.552
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.328
MDCK Permeability:  4.172603439656086e-05
Pgp-inhibitor:  0.996
Pgp-substrate:  0.5
Human Intestinal Absorption (HIA):  0.097
20% Bioavailability (F20%):  0.965
30% Bioavailability (F30%):  0.988

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.614
Plasma Protein Binding (PPB):  71.9985580444336%
Volume Distribution (VD):  1.014
Pgp-substrate:  19.056371688842773%

ADMET: Metabolism

CYP1A2-inhibitor:  0.023
CYP1A2-substrate:  0.118
CYP2C19-inhibitor:  0.082
CYP2C19-substrate:  0.328
CYP2C9-inhibitor:  0.077
CYP2C9-substrate:  0.043
CYP2D6-inhibitor:  0.182
CYP2D6-substrate:  0.057
CYP3A4-inhibitor:  0.359
CYP3A4-substrate:  0.418

ADMET: Excretion

Clearance (CL):  6.534
Half-life (T1/2):  0.119

ADMET: Toxicity

hERG Blockers:  0.27
Human Hepatotoxicity (H-HT):  0.474
Drug-inuced Liver Injury (DILI):  0.514
AMES Toxicity:  0.12
Rat Oral Acute Toxicity:  0.263
Maximum Recommended Daily Dose:  0.85
Skin Sensitization:  0.272
Carcinogencity:  0.084
Eye Corrosion:  0.003
Eye Irritation:  0.008
Respiratory Toxicity:  0.956

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC91730

Natural Product ID:  NPC91730
Common Name*:   QVDGHPMALHVSBN-WTLWSZCSSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  QVDGHPMALHVSBN-WTLWSZCSSA-N
Standard InCHI:  InChI=1S/C29H32O10/c1-14-17(31)12-29(36)24(38-25(35)16-9-7-6-8-10-16)22-27(5,23(34)21(33)20(14)26(29,3)4)18(32)11-19-28(22,13-37-19)39-15(2)30/h6-10,18-19,22,24,32,36H,11-13H2,1-5H3/t18-,19+,22-,24-,27+,28-,29+/m0/s1
SMILES:  CC(=O)O[C@@]12CO[C@@H]1C[C@@H]([C@@]1([C@@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)CC(=O)C(=C(C2(C)C)C(=O)C1=O)C)C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL450706
PubChem CID:   44575404
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0000676] Taxanes and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. leaf n.a. DOI[10.1016/j.tet.2004.10.110]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. twig n.a. DOI[10.1016/j.tet.2004.10.110]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota leaves and twigs n.a. n.a. PMID[12502326]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. n.a. n.a. PMID[15679325]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. twig n.a. PMID[15679325]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. leaf n.a. PMID[15679325]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. n.a. n.a. PMID[18220355]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT376 Cell Line A498 Homo sapiens Inhibition = 79.1 % PMID[463311]
NPT405 Cell Line NCI-H226 Homo sapiens Inhibition = 97.3 % PMID[463311]
NPT81 Cell Line A549 Homo sapiens Inhibition = 54.7 % PMID[463311]
NPT306 Cell Line PC-3 Homo sapiens Inhibition = 100.0 % PMID[463311]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC91730 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9929 High Similarity NPC197037
0.9857 High Similarity NPC217918
0.979 High Similarity NPC11588
0.979 High Similarity NPC134685
0.979 High Similarity NPC248265
0.979 High Similarity NPC219419
0.979 High Similarity NPC229545
0.9722 High Similarity NPC114357
0.9722 High Similarity NPC155329
0.9722 High Similarity NPC259144
0.9504 High Similarity NPC38696
0.9362 High Similarity NPC34012
0.9301 High Similarity NPC127857
0.9247 High Similarity NPC471103
0.9241 High Similarity NPC81698
0.9241 High Similarity NPC60509
0.9241 High Similarity NPC250046
0.9211 High Similarity NPC471493
0.9189 High Similarity NPC21410
0.9189 High Similarity NPC473670
0.9178 High Similarity NPC7095
0.9178 High Similarity NPC198455
0.9178 High Similarity NPC161239
0.9178 High Similarity NPC165260
0.9116 High Similarity NPC306799
0.9116 High Similarity NPC51602
0.9116 High Similarity NPC101043
0.9085 High Similarity NPC472547
0.9067 High Similarity NPC472393
0.906 High Similarity NPC228204
0.906 High Similarity NPC26033
0.9054 High Similarity NPC472548
0.9048 High Similarity NPC112216
0.9028 High Similarity NPC477894
0.9021 High Similarity NPC27377
0.9021 High Similarity NPC97947
0.9021 High Similarity NPC41481
0.9021 High Similarity NPC291599
0.9021 High Similarity NPC472576
0.9021 High Similarity NPC87448
0.9021 High Similarity NPC118080
0.9 High Similarity NPC106895
0.9 High Similarity NPC217091
0.8993 High Similarity NPC304876
0.8993 High Similarity NPC249471
0.8993 High Similarity NPC257213
0.8993 High Similarity NPC1173
0.8993 High Similarity NPC472022
0.8993 High Similarity NPC133430
0.8993 High Similarity NPC473414
0.8993 High Similarity NPC265395
0.8993 High Similarity NPC472005
0.8993 High Similarity NPC469477
0.8993 High Similarity NPC242262
0.8993 High Similarity NPC237549
0.8993 High Similarity NPC256142
0.8993 High Similarity NPC472030
0.8993 High Similarity NPC158333
0.8973 High Similarity NPC474935
0.8958 High Similarity NPC182869
0.8951 High Similarity NPC275592
0.8951 High Similarity NPC97667
0.8951 High Similarity NPC100913
0.8951 High Similarity NPC90614
0.8951 High Similarity NPC171207
0.8944 High Similarity NPC39549
0.8933 High Similarity NPC282239
0.8933 High Similarity NPC112523
0.8933 High Similarity NPC473632
0.8933 High Similarity NPC114410
0.8933 High Similarity NPC469730
0.8933 High Similarity NPC132599
0.8933 High Similarity NPC472549
0.8926 High Similarity NPC477905
0.8904 High Similarity NPC471107
0.8904 High Similarity NPC471100
0.8889 High Similarity NPC16912
0.8882 High Similarity NPC469399
0.8873 High Similarity NPC472551
0.8873 High Similarity NPC472372
0.8873 High Similarity NPC472374
0.8873 High Similarity NPC472545
0.8867 High Similarity NPC77719
0.8857 High Similarity NPC80599
0.8836 High Similarity NPC470152
0.8836 High Similarity NPC475759
0.8836 High Similarity NPC241951
0.8819 High Similarity NPC183270
0.8819 High Similarity NPC477904
0.8816 High Similarity NPC469771
0.8816 High Similarity NPC469417
0.8808 High Similarity NPC473611
0.8808 High Similarity NPC5115
0.8803 High Similarity NPC477893
0.8803 High Similarity NPC477896
0.8784 High Similarity NPC132652
0.8776 High Similarity NPC473088
0.8776 High Similarity NPC472575
0.8776 High Similarity NPC469349
0.8776 High Similarity NPC158663
0.8776 High Similarity NPC171525
0.8776 High Similarity NPC471104
0.8776 High Similarity NPC277053
0.8776 High Similarity NPC70403
0.8776 High Similarity NPC311825
0.8776 High Similarity NPC29704
0.8776 High Similarity NPC174982
0.8776 High Similarity NPC177940
0.8776 High Similarity NPC472572
0.8776 High Similarity NPC301946
0.8776 High Similarity NPC472571
0.8776 High Similarity NPC184817
0.8776 High Similarity NPC472568
0.8776 High Similarity NPC200471
0.8776 High Similarity NPC476973
0.8776 High Similarity NPC470157
0.8776 High Similarity NPC92867
0.8776 High Similarity NPC470159
0.8776 High Similarity NPC96903
0.8767 High Similarity NPC163087
0.8758 High Similarity NPC471102
0.875 High Similarity NPC11410
0.8733 High Similarity NPC470153
0.8723 High Similarity NPC209851
0.8723 High Similarity NPC472394
0.8716 High Similarity NPC20255
0.8716 High Similarity NPC469513
0.8707 High Similarity NPC476974
0.8707 High Similarity NPC472569
0.8707 High Similarity NPC475122
0.8707 High Similarity NPC472570
0.8707 High Similarity NPC25768
0.8707 High Similarity NPC57628
0.8707 High Similarity NPC163719
0.8707 High Similarity NPC11685
0.8707 High Similarity NPC95265
0.8707 High Similarity NPC70716
0.8707 High Similarity NPC125106
0.8707 High Similarity NPC80895
0.8707 High Similarity NPC471912
0.8707 High Similarity NPC472573
0.8707 High Similarity NPC95810
0.8707 High Similarity NPC188865
0.8699 High Similarity NPC472546
0.8684 High Similarity NPC251139
0.8671 High Similarity NPC291638
0.8671 High Similarity NPC472577
0.8671 High Similarity NPC17877
0.8671 High Similarity NPC195647
0.8671 High Similarity NPC66761
0.8667 High Similarity NPC470245
0.8667 High Similarity NPC254558
0.8667 High Similarity NPC473214
0.8658 High Similarity NPC473760
0.8649 High Similarity NPC125882
0.8649 High Similarity NPC472556
0.8639 High Similarity NPC95449
0.863 High Similarity NPC224491
0.8601 High Similarity NPC474608
0.86 High Similarity NPC476975
0.86 High Similarity NPC301556
0.86 High Similarity NPC471101
0.86 High Similarity NPC270590
0.86 High Similarity NPC92293
0.86 High Similarity NPC473215
0.86 High Similarity NPC266265
0.8591 High Similarity NPC477737
0.8591 High Similarity NPC209592
0.8591 High Similarity NPC478263
0.8591 High Similarity NPC48599
0.8582 High Similarity NPC473443
0.8581 High Similarity NPC34943
0.8553 High Similarity NPC22571
0.8553 High Similarity NPC469647
0.8553 High Similarity NPC469648
0.8553 High Similarity NPC138641
0.8553 High Similarity NPC283875
0.8533 High Similarity NPC281717
0.8533 High Similarity NPC327031
0.8526 High Similarity NPC476077
0.8523 High Similarity NPC478264
0.8514 High Similarity NPC91703
0.8511 High Similarity NPC225103
0.8503 High Similarity NPC213567
0.8487 Intermediate Similarity NPC469415
0.8487 Intermediate Similarity NPC472398
0.8471 Intermediate Similarity NPC43304
0.8471 Intermediate Similarity NPC477188
0.8471 Intermediate Similarity NPC477190
0.8467 Intermediate Similarity NPC473602
0.8467 Intermediate Similarity NPC240115
0.8451 Intermediate Similarity NPC472388
0.8446 Intermediate Similarity NPC192658
0.8442 Intermediate Similarity NPC469422
0.8442 Intermediate Similarity NPC469456
0.8442 Intermediate Similarity NPC34066
0.844 Intermediate Similarity NPC195224
0.8438 Intermediate Similarity NPC102465
0.8435 Intermediate Similarity NPC473613
0.8435 Intermediate Similarity NPC43241

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC91730 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8696 High Similarity NPD8368 Discontinued
0.8537 High Similarity NPD8407 Phase 2
0.8434 Intermediate Similarity NPD8434 Phase 2
0.8333 Intermediate Similarity NPD8361 Approved
0.8333 Intermediate Similarity NPD8435 Approved
0.8333 Intermediate Similarity NPD8360 Approved
0.8171 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.8046 Intermediate Similarity NPD8485 Approved
0.8039 Intermediate Similarity NPD7236 Approved
0.8 Intermediate Similarity NPD8424 Clinical (unspecified phase)
0.791 Intermediate Similarity NPD8486 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD7239 Suspended
0.7892 Intermediate Similarity NPD7799 Discontinued
0.7586 Intermediate Similarity NPD8150 Discontinued
0.7455 Intermediate Similarity NPD7057 Phase 3
0.7455 Intermediate Similarity NPD7058 Phase 2
0.7452 Intermediate Similarity NPD4628 Phase 3
0.7447 Intermediate Similarity NPD8462 Phase 1
0.7434 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7351 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7819 Suspended
0.7318 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD7473 Discontinued
0.7305 Intermediate Similarity NPD7075 Discontinued
0.7296 Intermediate Similarity NPD6190 Approved
0.7292 Intermediate Similarity NPD8404 Phase 2
0.7256 Intermediate Similarity NPD6599 Discontinued
0.7256 Intermediate Similarity NPD4380 Phase 2
0.7232 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD2629 Approved
0.7169 Intermediate Similarity NPD6801 Discontinued
0.7143 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD6232 Discontinued
0.7126 Intermediate Similarity NPD5844 Phase 1
0.7125 Intermediate Similarity NPD8166 Discontinued
0.7111 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD3817 Phase 2
0.7083 Intermediate Similarity NPD5402 Approved
0.7041 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7034 Intermediate Similarity NPD4198 Discontinued
0.7024 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD5760 Phase 2
0.7024 Intermediate Similarity NPD5761 Phase 2
0.7022 Intermediate Similarity NPD8313 Approved
0.7022 Intermediate Similarity NPD8312 Approved
0.7018 Intermediate Similarity NPD5494 Approved
0.7013 Intermediate Similarity NPD7008 Discontinued
0.7 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.6994 Remote Similarity NPD6799 Approved
0.6988 Remote Similarity NPD7458 Discontinued
0.6988 Remote Similarity NPD3226 Approved
0.6977 Remote Similarity NPD8127 Discontinued
0.6971 Remote Similarity NPD3818 Discontinued
0.6964 Remote Similarity NPD1934 Approved
0.6959 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6957 Remote Similarity NPD6534 Approved
0.6957 Remote Similarity NPD6535 Approved
0.6951 Remote Similarity NPD2533 Approved
0.6951 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6951 Remote Similarity NPD2532 Approved
0.6951 Remote Similarity NPD2534 Approved
0.6943 Remote Similarity NPD230 Phase 1
0.6937 Remote Similarity NPD2346 Discontinued
0.6935 Remote Similarity NPD7700 Phase 2
0.6935 Remote Similarity NPD7699 Phase 2
0.6931 Remote Similarity NPD7435 Discontinued
0.6923 Remote Similarity NPD2181 Clinical (unspecified phase)
0.6923 Remote Similarity NPD7961 Discontinued
0.6923 Remote Similarity NPD2801 Approved
0.6923 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6918 Remote Similarity NPD7305 Phase 1
0.6914 Remote Similarity NPD6398 Clinical (unspecified phase)
0.691 Remote Similarity NPD6764 Approved
0.691 Remote Similarity NPD6765 Approved
0.6905 Remote Similarity NPD7411 Suspended
0.6901 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6901 Remote Similarity NPD2182 Approved
0.6897 Remote Similarity NPD6010 Discontinued
0.6895 Remote Similarity NPD8320 Phase 1
0.6895 Remote Similarity NPD8319 Approved
0.6893 Remote Similarity NPD7074 Phase 3
0.6892 Remote Similarity NPD7741 Discontinued
0.6882 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6875 Remote Similarity NPD3751 Discontinued
0.6875 Remote Similarity NPD1609 Clinical (unspecified phase)
0.6872 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6867 Remote Similarity NPD5403 Approved
0.6864 Remote Similarity NPD37 Approved
0.6859 Remote Similarity NPD3764 Approved
0.6857 Remote Similarity NPD6166 Phase 2
0.6857 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6857 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6852 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6849 Remote Similarity NPD5951 Approved
0.6848 Remote Similarity NPD5401 Approved
0.6842 Remote Similarity NPD4967 Phase 2
0.6842 Remote Similarity NPD4966 Approved
0.6842 Remote Similarity NPD4965 Approved
0.6836 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6836 Remote Similarity NPD7054 Approved
0.6816 Remote Similarity NPD7685 Pre-registration
0.6816 Remote Similarity NPD6559 Discontinued
0.6813 Remote Similarity NPD2799 Discontinued
0.6807 Remote Similarity NPD6273 Approved
0.68 Remote Similarity NPD5125 Phase 3
0.68 Remote Similarity NPD5126 Approved
0.6798 Remote Similarity NPD7472 Approved
0.679 Remote Similarity NPD970 Clinical (unspecified phase)
0.6772 Remote Similarity NPD6782 Approved
0.6772 Remote Similarity NPD6776 Approved
0.6772 Remote Similarity NPD6779 Approved
0.6772 Remote Similarity NPD6778 Approved
0.6772 Remote Similarity NPD6777 Approved
0.6772 Remote Similarity NPD6781 Approved
0.6772 Remote Similarity NPD6780 Approved
0.677 Remote Similarity NPD2796 Approved
0.677 Remote Similarity NPD2935 Discontinued
0.6768 Remote Similarity NPD7274 Clinical (unspecified phase)
0.6763 Remote Similarity NPD6234 Discontinued
0.676 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6758 Remote Similarity NPD6785 Approved
0.6758 Remote Similarity NPD6784 Approved
0.6755 Remote Similarity NPD7457 Clinical (unspecified phase)
0.6754 Remote Similarity NPD7497 Discontinued
0.6752 Remote Similarity NPD2313 Discontinued
0.6747 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6747 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6747 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6744 Remote Similarity NPD3882 Suspended
0.6743 Remote Similarity NPD3787 Discontinued
0.6728 Remote Similarity NPD7702 Clinical (unspecified phase)
0.6722 Remote Similarity NPD7251 Discontinued
0.6718 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6718 Remote Similarity NPD7874 Approved
0.6713 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6711 Remote Similarity NPD6287 Discontinued
0.6708 Remote Similarity NPD1510 Phase 2
0.6707 Remote Similarity NPD3750 Approved
0.669 Remote Similarity NPD5048 Discontinued
0.6689 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6687 Remote Similarity NPD1549 Phase 2
0.6687 Remote Similarity NPD6651 Approved
0.6686 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6686 Remote Similarity NPD6959 Discontinued
0.6685 Remote Similarity NPD7228 Approved
0.6685 Remote Similarity NPD7808 Phase 3
0.6667 Remote Similarity NPD6099 Approved
0.6667 Remote Similarity NPD7696 Phase 3
0.6667 Remote Similarity NPD7697 Approved
0.6667 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7698 Approved
0.6667 Remote Similarity NPD6797 Phase 2
0.6667 Remote Similarity NPD6100 Approved
0.6667 Remote Similarity NPD9545 Approved
0.6667 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6647 Remote Similarity NPD7768 Phase 2
0.6647 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6646 Remote Similarity NPD2800 Approved
0.6632 Remote Similarity NPD7870 Phase 2
0.6632 Remote Similarity NPD7871 Phase 2
0.6631 Remote Similarity NPD6212 Phase 3
0.6631 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6631 Remote Similarity NPD6213 Phase 3
0.6628 Remote Similarity NPD1465 Phase 2
0.6627 Remote Similarity NPD3300 Phase 2
0.6626 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6626 Remote Similarity NPD7266 Discontinued
0.6626 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6622 Remote Similarity NPD690 Clinical (unspecified phase)
0.662 Remote Similarity NPD164 Approved
0.6615 Remote Similarity NPD7701 Phase 2
0.6615 Remote Similarity NPD6823 Phase 2
0.6609 Remote Similarity NPD3749 Approved
0.6606 Remote Similarity NPD7003 Approved
0.6606 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6605 Remote Similarity NPD7033 Discontinued
0.6605 Remote Similarity NPD3748 Approved
0.6605 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6603 Remote Similarity NPD5740 Clinical (unspecified phase)
0.6603 Remote Similarity NPD6085 Phase 2
0.6599 Remote Similarity NPD7094 Approved
0.6599 Remote Similarity NPD6858 Approved
0.6599 Remote Similarity NPD7801 Approved
0.6591 Remote Similarity NPD7199 Phase 2
0.6588 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6587 Remote Similarity NPD1511 Approved
0.6584 Remote Similarity NPD1607 Approved
0.6582 Remote Similarity NPD8151 Discontinued
0.6577 Remote Similarity NPD7115 Discovery
0.6564 Remote Similarity NPD5408 Approved
0.6564 Remote Similarity NPD5406 Approved
0.6564 Remote Similarity NPD5404 Approved
0.6564 Remote Similarity NPD5405 Approved
0.6562 Remote Similarity NPD943 Approved
0.6562 Remote Similarity NPD1240 Approved
0.6549 Remote Similarity NPD1929 Approved
0.6549 Remote Similarity NPD1930 Approved
0.6549 Remote Similarity NPD1931 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data